In addition, ablating PTHR1 in epithelial tissue and inhibiting the receptor with an antibody did not prevent the activation of STAT5 and development of secretory phenotypes or prevent the rapid formation of mammary tumors [41], providing further evidence that PTHrP intracrine signaling not only occurs in breast tumors, but appears to drive major cell growth programs. This evidence concerns the gene PTH1R and breast cancer.